Debt Financing - New Haven Pharmaceuticals - Aug 17, 2016 Funding Round Profile - Cointime

Bitcoin $80,311.77 +5.08%
Ethereum $3,209.46 +4.04%
BNB $633.20 +2.72%
Optimism $1.67 +5.06%
Arbitrum $0.64 +7.03%
Solana $210.32 +5.89%
Polygon $0.42 +11.33%
Cosmos $5.43 +15.41%
Avalanche $32.48 +11.88%

Bitcoin $80,311.77 +5.08%
Ethereum $3,209.46 +4.04%
BNB $633.20 +2.72%
Optimism $1.67 +5.06%
Arbitrum $0.64 +7.03%
Solana $210.32 +5.89%
Polygon $0.42 +11.33%
Cosmos $5.43 +15.41%
Avalanche $32.48 +11.88%

New Haven Pharmaceuticals

company

Funding Round

Debt Financing

Money Raised

$ 602.22K

Propotion

-

Post Valuation

-

Current Round Investors

Investor Name	Invest Money	Lead Investor	Propotion
Advantage Capital	-	-	-	Detail

Historical Financing

Announced Date	Round	Money Raised	Investors
Dec 31, 2013	Debt Financing	0	Advantage Capital	Detail
Oct 29, 2012	Series A	$ 6.49M	Advantage Capital,EJ Funds	Detail
Sep 30, 2012	Series Unknown	0	Advantage Capital	Detail
Oct 7, 2015	Debt Financing	$ 6.30M	Horizon Technology Finance	Detail
Oct 23, 2014	Series B	$ 11.78M	EJ Funds	Detail